EUVIMEDEUVIMED entdecken
Crossref

Glucose-Independent Metabolic Signatures of SGLT2 Inhibition in Diabetic Kidney Disease: Integrated Insights from Mendelian Randomization and Transcriptomics

Yang Zhou, Jie Peng, Xuchang Zhou, Yucheng Wang, Guolin Hong, Xinguo Zhuang

Diabetes & Metabolism Journal · 07.08.2026

DOI: 10.4093/dmj.2025.1273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, online erschienen am 07.08.2026. Verfasst von Yang Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; School of Basic Medicine, Pek…. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Diabetic nephropathiesMendelian randomization analysisMetabolomicsSodium-glucose transporter 2 inhibitorsTranscriptome

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; School of Basic Medicine, Peking Union Medical College, Beijing, China.
  • Department of Emergency Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Rehabilitation Medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Department of Psychiatry, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of Laboratory Medicine, Xiamen Key Laboratory of Genetic Testing, The First Affiliated Hospital of Xiamen University, School of Medicine, State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Bio…

Zitieren

APA

Zhou, Y., Peng, J., Zhou, X., Wang, Y., Hong, G., & Zhuang, X. (2026). Glucose-Independent Metabolic Signatures of SGLT2 Inhibition in Diabetic Kidney Disease: Integrated Insights from Mendelian Randomization and Transcriptomics. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2025.1273

Vancouver

Zhou Y, Peng J, Zhou X, Wang Y, Hong G, Zhuang X. Glucose-Independent Metabolic Signatures of SGLT2 Inhibition in Diabetic Kidney Disease: Integrated Insights from Mendelian Randomization and Transcriptomics. Diabetes & Metabolism Journal. 2026. doi:10.4093/dmj.2025.1273

BibTeX
@article{Zhou2026,
  author = {Zhou, Yang and Peng, Jie and Zhou, Xuchang and Wang, Yucheng and Hong, Guolin and Zhuang, Xinguo},
  title = {Glucose-Independent Metabolic Signatures of SGLT2 Inhibition in Diabetic Kidney Disease: Integrated Insights from Mendelian Randomization and Transcriptomics},
  journal = {Diabetes & Metabolism Journal},
  year = {2026},
  doi = {10.4093/dmj.2025.1273}
}
Kostenlos starten →